865 Effects of radium-223 dichloride (Ra-223) on total alkaline phosphatase (ALP) and prostate-specific antigen (PSA) in patients with castration-resistant prostate cancer (CRPC) and symptomatic bone metastases from the phase 3 ALSYMPCA trial

2014 ◽  
Vol 13 (1) ◽  
pp. e865 ◽  
Author(s):  
D. Heinrich ◽  
C. Parker ◽  
M. Shan ◽  
S. Wilhelm ◽  
J. Garcia-Vargas ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Alkaline Phosphatase ◽  
Bone Metastases ◽  
Specific Antigen ◽  
Castration Resistant Prostate Cancer ◽  
Total Alkaline Phosphatase ◽  
Phase 3 ◽  
Castration Resistant ◽  
Radium 223 ◽  
Total Alkaline

scholarly journals Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial

2018 ◽  
Vol 73 (3) ◽  
pp. 427-435 ◽  
Author(s):  
Christopher C. Parker ◽  
Robert E. Coleman ◽  
Oliver Sartor ◽  
Nicholas J. Vogelzang ◽  
David Bottomley ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Bone Metastases ◽  
Castration Resistant Prostate Cancer ◽  
Phase 3 ◽  
Cancer Trial ◽  
Castration Resistant ◽  
Radium 223
Sign in / Sign up

Export Citation Format

Share Document